EN

EYEASPIS RE-D

EYEASPIS RE-D

A highly concentrated and re-esterified biomarine formulation for Diabetic Retinopathy (4 clinical studies).

Eyeaspis Re-D is a specially formulated dietary supplement that addresses a fundamental need for patients at risk of developing Diabetic Retinopathy. Eyeaspis Re-D as part of the daily regimen can slow the advancement to Diabetic Retinopathy and to assist in delaying vision loss.

Eyeaspis Re-D is produced in a purified re-esterefied triglyceride form (rTG) provided up to 1200 mg of specific Omega-3 as EPA and DHA in a 1:5 concentration. Researches has shown that Omega-3s in the same form as found in nature and cleaned from impurities provides 124% bioavailability compared to natural fish oil. This means that more of the active Omega-3s (EPA and DHA) are used by the body for enhancing nutritional benefit.

It has been shown in clinical studies, published in great journals, as JAMA ophthalmology-Predimed Trial & Retina, that specially formulated Omega-3 fatty acids can help reduce the risk and slow the advancement to diabetic retinopathy.

Eyeaspis Re-D is an essential nutrient that has shown an almost 50% decrease in risk of sight threatening Diabetic Retinopathy. It supports retinal cellular metabolism, structure and function and helps to suppress retinal inflammation

Eyeaspis Re-D is manufactured in Norway in certified facilities. Every batch is tested for over 400 contaminants by an outside third-party lab to ensure quality and purity standards.

Commercial rights & brand holder: Aniva International S.A.